DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Braun J, Deodhar A, Landewe R. et al.
Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies.
RMD Open 2018;
4: e000749 doi: 10.1136/rmdopen-2018-000749
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.